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Clinical Trial Design - Effect of Prone Positioning on Clinical Outcomes in Infants
and Children With Acute Respiratory Distress Syndrome
Abstract
Purpose
This paper describes the methodology of a clinical trial of prone positioning in pediatric patients with
acute lung injury (ALI). Nonrandomized studies suggest that prone positioning improves oxygenation in
patients with ALI/acute respiratory distress syndrome without the risk of serious iatrogenic injury. It is not
known if these improvements in oxygenation result in improvements in clinical outcomes. A clinical trial
was needed to answer this question.
Materials and Methods
The pediatric prone study is a multicenter, randomized, noncrossover, controlled clinical trial. The trial is
designed to test the hypothesis that at the end of 28 days, children with ALI treated with prone positioning
will have more ventilator-free days than children treated with supine positioning. Secondary end points
include the time to recovery of lung injury, organ failure–free days, functional outcome, adverse events,
and mortality from all causes. Pediatric patients, 42 weeks postconceptual age to 18 years of age, are
enrolled within 48 hours of meeting ALI criteria. Patients randomized to the prone group are positioned
prone within 4 hours of randomization and remain prone for 20 hours each day during the acute phase of
their illness for a maximum of 7 days. Both groups are managed according to ventilator protocol,
extubation readiness testing, and sedation protocols and hemodynamic, nutrition, and skin care
guidelines.
Conclusions
This paper describes the process, multidisciplinary input, and procedures used to support the design of
the clinical trial, as well as the challenges faced by the clinical scientists during the conduct of the clinical
trial.
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Abstract
Purpose— This paper describes the methodology of an ongoing clinical trial of prone positioning
in pediatric patients with acute lung injury (ALI). Nonrandomized studies suggest that prone
positioning improves oxygenation in patients with ALI/ARDS without the risk of serious iatrogenic
injury. It is not known if these improvements in oxygenation result in improvements in clinical
outcomes. A clinical trial was needed to answer this question.
Materials and Methods— The pediatric prone study is a multi-center, randomized, non-crossover,
controlled clinical trial. The trial is designed to test the hypothesis that at the end of 28 days, children
with ALI treated with prone positioning will have more ventilator free days than children treated
with supine positioning. Secondary endpoints include the time to recovery of lung injury, organ
failure free days, functional outcome, adverse events, and mortality from all causes. Pediatric
patients, 42 weeks post-conceptual age to 18 years of age, are enrolled within 48 hours of meeting
ALI criteria. Patients randomized to the prone group are positioned prone within 4 hours of
randomization and remain prone for 20 hours each day during the acute phase of their illness for a
maximum of 7 days. Both groups are managed according to ventilator protocol, extubation readiness
testing, and sedation protocols and hemodynamic, nutrition and skin care guidelines.
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Conclusions— This paper describes the process, multidisciplinary input, and procedures used to
support the design of the clinical trial, as well as the challenges faced by the clinical scientists during
the conduct of the clinical trial.
Keywords
Clinical trial; Multisite study; Research methods; Adult Respiratory Distress Syndrome (ARDS);
acute lung injury; prone; position
Acute respiratory distress syndrome (ARDS), a diffuse and overwhelming inflammatory
reaction of the pulmonary parenchyma to a variety of catastrophic medical conditions, results
in high morbidity, mortality and financial burden (1–4). ALI/ARDS is acute in onset and is
characterized by arterial hypoxemia resistant to oxygen therapy and diffuse pulmonary
infiltrates without evidence of left atrial hypertension (2). ARDS is at the severe end of the
ALI spectrum. ALI is defined by a PaO2/FiO2 ratio (PF ratio) ≤ 300 mm Hg whereas ARDS
is defined by PF ratio ≤ 200 mm Hg (regardless of positive end-expiratory pressure [PEEP]
level).
Although lifesaving, the ventilation strategy that maintains adequate gas exchange in patients
with ALI/ARDS may exacerbate lung inflammation and injury (2,5–6). ALI/ARDS produces
a diffuse lung injury that is mechanically heterogeneous at risk for further injury. Specifically,
when supine, the reduced volume of the nondependent aerated lung is at risk for alveolar
overdistention with conventional ventilator strategies while the interaction of cyclic ventilation
and lung injury causes repetitive recruitment and de-recruitment with consequent
biomechanical strain in dependent lung regions (7).
Morbidity and mortality from ARDS may be reduced using lung protective ventilation
strategies. Prone positioning, as first suggested by Bryan in 1974 (8), is a relatively simple
maneuver that improves oxygenation and lung mechanics in adults with severe impairments
of gas exchange (9–11). Our preliminary study showed that pediatric patients improved their
oxygenation without serious iatrogenic injury after early, repetitive and prolonged prone
positioning (12). The improved oxygenation resulting from prone positioning allows a
reduction in the intensity of ventilator support, e.g., reduced FiO2 and mean airway pressure
which may decrease ventilator associated lung injury (VALI) and facilitate patient recovery.
The International Consensus Conference in Intensive Care Medicine: Ventilator-associated
Lung Injury in ARDS proposed that prone positioning may prevent VALI but recommended
randomized trials to evaluate its short and long-term risk and benefit (6).
To date, two separate clinical trials of prone positioning in adult patients with ALI/ARDS have
yielded disappointing results. Gattinoni et al. (13) conducted a multicenter randomized clinical
trial in patients with ALI/ARDS comparing conventional treatment (in the supine position) to
a strategy of placing patients in a prone position for six or more hours daily for 10 days.
Although prone position improved oxygenation, the intervention did not improve patient
survival.
Mancebo et al. (14) replicated the Gattinoni study with a mortality endpoint but instituted
ventilation protocols in both groups and placed patients prone early in the course of their disease
for 20 hours daily. This study closed following an interim analysis without answering their
research question because of difficulties with patient accrual. The 25% relative reduction in
mortality in the prone group was not sufficient to reach statistical significance.
Our study design addresses the major criticisms of these two papers. Specifically, the current
study – the first randomized study of prone positioning in a pediatric population -institutes
early entry criteria, a 20-hour protocol, enhanced control in both groups (positional and nonJ Crit Care. Author manuscript; available in PMC 2007 January 18.
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positional protocols) and the outcome of ventilator-free days rather than mortality. We suspect
that pediatric patients, whose chest wall compliance is higher than in adults, are more likely
to do well with prone positioning making this pediatric study important in the face of
disappointing adult trials.
This paper describes the process, multidisciplinary input, procedures, and challenges addressed
by a group of pediatric critical care clinical researchers during the conduct of a multisite clinical
trial. The nuances of this clinical research study are presented to allow this study to be compared
to existing and future pediatric ALI research and assist future pediatric critical care scientists
in the conduct of clinical trails.

OVERVIEW
This study is a multicenter, randomized, non-crossover, controlled clinical trial comparing the
effects of early, repeated, and prolonged prone positioning with supine positioning in the
treatment of 180 children with ALI/ARDS. The trial, which enrolled its first patient in
September 2001, is funded by the National Institute of Nursing Research.

ENDPOINTS
Primary outcome
The primary outcome for this study is ventilator free days. This outcome, commonly used by
the ARDS network (15), is defined as the number of days from enrollment in the study (Day
1) to Day 28 during which a patient breathes without assistance if the period of unassisted
breathing lasted at least 48 consecutive hours. Our definition of assisted breathing includes any
positive pressure support > 5 cmH2O even if applied non-invasively (for example, BiPAP).
Ventilator-free days is a composite end point that reflects a difference in mortality and
ventilator days among survivors. We recognize that interpretation of composite end-points is
often challenging (16). Unfortunately the “cleaner” end-point of mortality is not practical
because unacceptably large sample sizes would be required to have adequate statistical power
to detect differences in mortality after supine vs. prone positioning. Although epidemiological
data remain unpublished, mortality rates in pediatric patients with ARDS are presumed lower
than those in adult patients (17). Using the duration of mechanical ventilation is also
unacceptable because therapies that decrease mortality may increase the duration of mechanical
ventilation. Practicality aside, ventilator free days to Day 28 is a clinically relevant end-point
because increasing the number of days a patient is not supported on mechanical ventilation
limits iatrogenesis: for example, ventilator associated pneumonia, hazards of immobility, and
narcotic exposure.
Secondary outcomes
Secondary endpoints include the time to recovery of lung injury, organ failure free days,
functional outcome, adverse events, and mortality from all causes. Time to recovery of lung
injury is defined as the number of days from randomization to achieve an oxygenation criterion,
i.e., an oxygenation index (OI = [mean airway pressure/ PF ratio] x 100) of 6 or lower for 24
consecutive hours through Day 28. Use of the OI provides an objective measure of the patient’s
recovery from ALI/ARDS and capacity to wean from mechanical ventilation (18). Organ
failure free days are defined as the number of days from Day 1 to Day 28 in which a patient is
without clinically significant non-pulmonary organ dysfunction. Organ dysfunction
parameters are derived from the PeLOD score for the neurological, cardiovascular, renal,
hematological and hepatic systems (19) (see http://www.sfar.org/scores2/pelod2.html).
Differences in cognitive impairment and overall functional health from PICU admission to
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hospital discharge (or Day 28), are evaluated using the Pediatric Cerebral Performance
Category (PCPC) Score and Pediatric Overall Performance Category (POPC) scales (20).

SELECTION OF STUDY SUBJECTS AND THE CONSENT PROCESS
All intubated mechanically ventilated patients in each participating center’s pediatric ICU are
screened for study eligibility each day. Patients are considered eligible to participate in the
study when all inclusion criteria are confirmed (Table 1) and no exclusion criteria are present
(Table 2). Exclusion criteria focus on patients who are likely to be too physiologically unstable
to tolerate a change in position, patients who have hypoxemia without ALI/ARDS, and patients
who have, or are likely to develop, conditions in which the duration of mechanical ventilation
is unlikely to be altered by an improvement in lung function.
Twelve pediatric intensive care units received Institutional Review Board approval to
participate in this clinical trial (Appendix 1). After the patient’s eligibility status is confirmed
with the care team, parents or legal guardian(s) are asked to provide informed consent for their
child’s participation in the study. Several sites have multilingual consents to accommodate
diverse patient populations. Given that all patients are sedated on mechanical ventilation, none
are able to provide assent.

TREATMENT GROUPS
ASSIGNMENT - Randomization
Randomization assignments (using permuted blocks of size 2 and 4, presented in random order)
are stratified by center. Each hospital has received serially numbered, opaque, sealed envelopes
containing study assignments. Eligible patients are randomized within 48 hours of meeting
ALI criteria to either prone or supine positioning for the acute phase of their ALI/ARDS illness
for a maximum of 7 days of treatment (Fig. 1).

STUDY PROCEDURES
The acute phase of illness is defined as the time interval between meeting ALI criteria to
meeting extubation readiness testing criteria; specifically, spontaneous breathing, OI < 6, and
a decrease and/or plateau in ventilator support over the previous 12 hours (18). The seven day
maximum limit was selected because it reflects the acute phase of ARDS illness where
endothelial and epithelial cell inflammation and injury are prevalent (21). Also, during our
Phase One study, only 10% of patients were positioned prone beyond seven days (12). After
7 days of treatment, all patients who are still intubated receive the standard of care (supine
positioning). Other than prone or supine positioning, patients in both groups are managed
according to ventilator protocol, extubation readiness testing, and sedation protocols and
hemodynamic, nutrition and skin care guidelines during the 28 day period. These explicit
decision-support tools are necessary to reduce clinician variation in managing similar clinical
situations (22).

INTERVENTIONS
Positioning Protocol
Prone positioning is accomplished by rigid attention to detail that was developed during our
Phase One study (12). Individually sized head, chest, pelvic, distal femoral, and lower limb
cushions are created using pressure relieving material (covered Eggcrate; Span American
Medical Systems, Greenville, SC; or Bendy® Bumper; Medical Ventures; Weymouth, MA).
The cushions allow the patient’s abdomen to be supported above the patient’s bed surface and
provide skin protection. The chest cushion should measure slightly less than the right-to-left
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greater tubercle of the upper arm; equal the patient’s anterior-posterior width; and wide enough
to cover the patient’s sternum when compressed. The pelvic cushion should measure slightly
smaller than the right-to-left iliac crest and be slightly smaller than the patient’s anteriorposterior width. The head pillow should allow the patient’s head to be slightly higher than the
chest wedge. A small cushion should be placed under the distal femur to elevate the patient’s
knees off the bed. The lower limb cushion should elevate the patient’s toes off the bed. When
properly positioned the patient’s body should fold into the cushions, the abdomen should not
be compressed and the shoulders should not be hyperextended.
Prone positioning results in cephalad movement of ETT within the trachea. To prevent
inadvertent endotracheal tube (ETT) dislodgement, ETT position is checked before prone
positioning. The tip of the ETT should be deeper than one third of the total length of the thoracic
trachea to prevent it from moving into the cervical trachea when prone (23). To prevent oral
pressure ulcers the ETT is secured to the upper lip rather than the corner of the mouth.
Before prone positioning the respiratory therapist checks for the presence of an ETT leak and,
if present, inflates the cuff to minimize loss of lung volume. The nurse checks the security of
all invasive lines and resecures them as necessary. If the patient is receiving a pharmacologic
paralytic agent or if incomplete eyelid closure is present, eye protection is provided to prevent
corneal abrasions. Specifically, the nurse cleanses, lubricates, and then covers both eyes with
a moisture shield (24).
The site nurse coinvestigator or research assistant in collaboration with the bedside nurse/
respiratory therapist team coordinates each turn. Depending on the size of the patient, each
turn procedure (supine to prone; prone to supine) involves 2 to 4 individuals including the
patient’s nurse and respiratory therapist. During the turn procedure, the respiratory therapist is
assigned the primary responsibility of ETT protection. The repositioning technique is reviewed.
Infants/toddlers are lifted up, turned 45 degrees, turned prone and then placed on their cushions
after the turn. School aged and adolescent patients are turned using the mummy technique. The
patient is positioned supine in the center of the bed. The following are layered over the patient:
draw sheet or pads, chest and pelvic cushions then full sheet. The sheet is then tucked under
the patient’s arms and the sheet under the patient is loosened from the bed frame and brought
over the patient’s arms. The patient is then positioned on the side of the bed away from the
ventilator, turned 45 degrees toward ventilator, then positioned prone on cushions and new
linen.
During each turn the patient’s head is kept in alignment with the body, avoiding
hyperextension; the patient’s arms are contained next to the torso; and the patient’s lower legs
are crossed with the upper leg pointed in the direction of the turn.
Patients are turned toward the ventilator without disconnecting from the ventilator. If the patient
requires ETT suctioning, turning is delayed until the patient is suctioned and has returned to
their pre-suctioning ventilator settings. If deemed necessary by the care team, the FiO2 may
be manipulated to maintain target SpO2 during repositioning. All other ventilator settings
remain constant until the one hour post positioning study blood gas is obtained.
If the patient is supported on HFOV the care team anticipates the need to increase the
oscillator’s power to maintain the same PaCO2 while in the prone position. Bronchial drainage
may increase while prone so frequency of suctioning is reevaluated.
When prone, the patient’s head pillow is positioned to prevent extreme lateral head rotation.
The patient’s upper arms remain at their side and their lower arms are flexed up. The lower
limbs are cushioned so that the patient’s knees and toes are positioned off the bed.
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Prone positioning includes a 20-hour cyclic rotation from full prone to right lateral/prone to
full prone to left lateral/prone then to full prone. When tilted into a lateral prone position, the
patient’s dependent lower arm is repositioned against their torso and their non-dependent lower
arm is flexed at the elbow and positioned up towards the patient’s head. Ten hours into the
prone position the patient’s upper chest and head are lifted so that their head can be turned in
the opposite direction. If supported on HFOV, this process is facilitated by the use of flexible
tubing.
Unless a change in management is anticipated, procedures that require anterior access to the
patient are accomplished during the 4-hour supine period. During the patient’s 20-hour prone
period, the care team can reposition a patient supine for an assessment or clinical procedure.
The patient is returned prone, to complete their rotation, after the evaluation or procedure is
completed.
After Day 7, if withdrawal of prone positioning results in a significant increase in ventilator
support (e.g., FiO2 >0.6 persisting for 2 hours or more) the care team can elect to continue
prone positioning until supine positioning is tolerated.
Non-Positional Protocols
Drafts of the non-positional protocols and guidelines were developed given the best evidence
available in January 2000. These decision-making tools were finalized during the startup
investigator meeting using a consensus process involving pediatric critical care nurses,
physicians and respiratory therapists. Whereas guidelines provide general principles in
management, protocols are detailed and generate patient-specific instructions that can be
carried out by different clinicians with little random variation (22).
The ventilator protocol reflects the International Consensus Conference in Intensive Care
Medicine: Ventilator Associated Lung Injury in ARDS (6) recommendations using a low tidal
volume/open lung strategy (15,25–28) and permissive hypercapnea (29–30) (Figure 2). The
goal is adequate oxygenation and ventilation. The protocol recommends a PaO2 range of 50–
80 mmHg or a SpO2 range of 85–92% and does not specify a PaCO2 range as long as the pH
remains between 7.25 and 7.45. Other than transient maneuvers in response to patient
hypotension and/or desaturation, the FiO2 is adjusted according to the ARDSNet PEEP/FiO2
grid (15). One change was made to this grid; an incremental PEEP step of 6 cmH20 was inserted
on weaning from 8 cmH20 to 5 cmH20. After pilot testing, clinicians felt the 3 cmH20 PEEP
drop to be excessive in pediatric patients. Exhaled tidal volume (Vt), as measured at the airway
using a CO2SMO+ monitor (Novametrix Medical Systems Inc; Wallingford, CT, USA), is
limited to 6 mL/kg of ideal body weight. The minimum Vt is 4 ml/kg and the maximum Vt is
6 ml/kg unless measured dead space per CO2SMO+ is > 0.7. The head of the bed is elevated
30 degrees in supine patients and placed in a 30 degree reverse trendelenburg position in prone
patients to reduce the risk of nosocomial pneumonia (31).
Ideal body weight (IBW) was determined for gender and recumbent length to 3 years of age
using the National Center for Health Statistics growth charts. Predicted weight charts for
gender/stature beyond 3 years of age do not exist so the predicted body weight table was
generated by identifying the 50th percentile weight associated with age then linking that data
to the 50th percentile height (32).
Although sites can elect to transition a patient to high frequency oscillatory ventilation (HFOV)
when a patient’s OI is 15 and rising, the use of HFOV is mandated with an OI of 20. All centers
present during the consensus meeting used HFOV as a ventilation strategy in managing patients
with ALI/ARDS. Mandating the use of HFOV at a consistent hypoxic threshold provided the
requisite control necessary in the clinical trial. When supported on HFOV the patient’s mean
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airway pressure is adjusted to maintain optimal lung volume allowing a reduction in FiO2 ≤
0.6 without clinical or radiological evidence of hyperinflation: no signs of decreased cardiac
output and/or the level of the diaphragm visible greater than the ninth rib (28).
No attempt is made to standardize suctioning practices across the study sites. Care is taken to
re-recruit lung volume after all ventilator disconnects and after endotracheal suctioning. This
is accomplished by volume recruitment maneuvers using sustained inflation (e.g., 30–40
seconds) at higher pressures (e.g., 30–40 cm H20) or, if supported on HFOV, temporary 10%
increases in mean airway pressure.
Once the patient demonstrates: (a) spontaneous breathing; (b) OI < 6; and (c) a decrease and/
or plateau in ventilator support over the previous 12 hours (18), the acute phase of ALI ends
(prone positioning stops) and the patient is tested for extubation readiness (33) (Figure 3).
Patients are ready for extubation if they maintain SpO2, Vt, and respiratory rate goals. The
patient’s care team is advised of the test results. The action of the care team is noted as
extubation may be delayed for non-pulmonary issues. If the patient fails the extubation
readiness test because of excessive sedation then sedation is weaned and the patient is retested
at 16:00.
Sedation in both groups is managed by the nurse-implemented sedation protocol (34). Essential
elements include sedation scoring every four hours using the pediatric Modified Motor Activity
Assessment Scale (MMAAS (35–36), pain scoring every fours hours using an age-appropriate
pain instrument (FLACC in patients 2 weeks to 7 years of age (37); Individualized Numeric
Rating Scale in nonverbal or cognitively impaired patients (INRS; 38)), and the use of
benzodiazepine and opioid continuous infusions. The algorithm recommends a level of
sedation that matches the patient’s trajectory of illness. In the acute phase, decreases in sedation
are not recommended. In the plateau phase, a daily “wake-up” test is performed after which
the sedatives are restarted at half of the pre-wake up dose (39) then titrated every eight hours
to maintain the prescribed level of comfort. In the ventilator weaning to extubation phase,
patients who received opioid infusions for more than 5 days are first weaned from their opioid
infusions over 48 hours. The benzodiazepine infusion is converted to intermittent intravenous
or enteral dosing. Once the opioid infusion is discontinued, the benzodiazepine is weaned over
10 days. Opioids and benzodiazepines are discontinued without taper in patients receiving these
agents for less than 5 days.
The Hemodynamic Management Guideline identifies a fluid conservative strategy with a goal
of adequate cardiac output to meet the metabolic needs of the patient (40). The Nutrition
Guideline identifies the goal of adequate calories to sustain the metabolic needs of the patient
(41). Unless contraindicated (post-operative ileus, intestinal ischemia, and intestinal
obstruction), all patients are advanced to full transplyoric enteral nutrition (42). The Skin Care
and Pressure Ulcer Guideline identifies the goal of skin integrity. A daily skin assessment is
performed and recorded on each patient during the acute treatment phase. Universally accepted
prevention strategies are used to prevent pressure ulcers (43–45). Pressure ulcers are staged
and managed according to National Pressure Ulcer Advisory Panel recommendations (46–
47). Patients developing a new Stage III+ pressure ulcer exit the study.

STUDY VARIABLES
The data set will provide a rich repository of information describing the patient population and
trajectory of illness of pediatric patients with ALI/ARDS. At enrollment, patient demographics,
baseline assessment, past medical history, ALI/ARDS trigger, and admission functional health
and PRISM III are recorded.
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During the acute phase up to Day 7, ventilator settings, i-Stat®arterial blood gases,
CO2SMO+ exhaled data, MMAAS and pain scores, total sedative dose, neuromuscular
blockade and alkalizing agent use, and chest XRay data are collected. Daily measures are
obtained when both groups are in the supine position. Patients randomized to prone positioning
also have their physiologic values and arterial blood gases assessed after each supine-to-prone
turn and before and after each prone-to-supine turn to describe the patient’s response to prone
repositioning. To avoid bias, study blood gases are not available to the care team for clinical
decision-making. Clinicians are encouraged to obtain data elements according to their clinical
judgment.
In addition, daily (to Day 28) vital signs, pulmonary status and respiratory support, extubation
readiness, fluid and nutritional balance, organ functions are documented. Data elements are
collected only if available and reflect blood studies and values obtained closest to 08:00.
On Day 28, patient status is verified and data are summarized. Specifics include the reason for
ending the acute treatment phase, crucial study dates, functional status at discharge, and
discharge location. If discharged, parents are directly contacted to verify the patient’s continued
recovery. In the event of patient death, the primary and secondary causes of death as specified
on the patient’s death certificate are recorded. Protocol deviations and adverse events are
monitored throughout the study period and reported to the Data Safety Monitoring Board.

SAMPLE SIZE
The sample size estimates for this study are based conservatively on the anticipated proportions
of patients alive and ventilator free at the end of 28 days. We assumed that this will occur in
approximately 65% of patients in the supine group and 90% of patients in the prone group,
based on our prior studies (12,18). We also assumed that about 10% of patients may be
erroneously positioned or their provider may decide to discontinue a patient’s assigned
treatment regimen. Using these assumptions, we calculated a sample size of 90 patients per
group. This sample size provides greater than 90% power to detect a probability of 0.65 that
the number of ventilator free days for a patient in the experimental group is higher than that of
a patient in the control group, using a Wilcoxon rank-sum (Mann-Whitney U) test.

DATA SAFETY MONITORING
The Principal Investigator appointed a four member multidisciplinary independent Data Safety
Monitoring Board (DSMB). The DSMB is responsible for monitoring patient safety, protocol
adherence, data quality and patient accrual rates. The DSMB receives quarterly reports and
participates in twice yearly conference calls. They will also conduct an interim analysis after
50% of patients have completed the study. Group sequential monitoring will be used to stop
the study if large treatment differences appear before the end of the study and the method of
stochastic curtailing will be used to stop the study early if there is little chance of finding a
significant difference between groups. The effect of an O’Brien Fleming rule on the sample
size for the study was examined. Assuming a single interim data analysis when half of the
patients have completed the study, the null hypothesis is rejected if P < 0.006 (|Z| > 2.74); the
null hypothesis is accepted if P > 0.52 (−0.70 < Z < 0.70).

QUALITY CONTROL PROCEDURES
Before enrolling patients, all nurse coinvestigators attended a project initiation meeting and
completed a competency-based training program. Study nurses at each site were required to
review the Case Report Forms (CRF) and Manual of Operations (MOO), view two videotapes
demonstrating prone positioning, and complete and pass a scenario-based post-test. Continued
quality is assessed during site visits conducted by a mastered-prepared pediatric critical care
J Crit Care. Author manuscript; available in PMC 2007 January 18.
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nurse auditor. The review includes examination of all study procedures, randomization check,
review of completed CRFs and procedures to resolve queries. Research Assistants are observed
conducting randomly selected protocol duties. Site visit checklists are used and reports are
generated after each visit. All sites enact the quality improvement plan if they do not enroll a
patient in 12 weeks. When enacted the plan must be completed in one month and a report of
completion sent to the coordinating center. Sites not enrolling a patient in one year are placed
on 3 months probation. Sites on probation must enroll a patient or withdraw from the study
group.

STUDY DESIGN CHALLENGES
Several unique methodological challenges have presented themselves during the conduct of
this clinical trial. These challenges can be considered within three major categories: patient
enrollment, controlling bias, and interdisciplinary coordination.
From the onset we predicted a less than 3% incidence of ALI in all intubated mechanically
ventilated PICU patients (1,3). Given this low frequency and the requirement to identify all
eligible patients as soon as possible after meeting ALI criteria, we instituted a protocol of daily
screening and weekly faxing of screening logs to the coordination center. The coordinating
center monitors and projects enrollment numbers (based upon a clinical site’s established
enrollment history) that are reviewed quarterly by the Steering and Operations Committees.
Given the rapid evolution of critical care therapies, it is critical that data collection be completed
in the shortest period of time. Based upon our enrollment projections, an additional eight
clinical sites joined and four clinical sites resigned from our study group. The latter did not
have a sufficient patient population necessary to maintain competency in study procedures.
Approximately half of all eligible patients are enrolled. The primary reason for this eligibilityenrollment gap is parent refusal. Our parental refusal rate averages 36% to date, but increased
from 27% to 53% after implementation of the HIPAA regulations. To address the volume of
parent refusals, the Steering and Operations Committee reviewed the nurse-physician team
consent process enacted when a parent is emotionally capable of giving informed consent.
The enrollment criteria for our study eventually overlapped with several simultaneous pediatric
critical care clinical trials. Sharing schemes were agreed upon by the principal investigators
and proposed to the clinical sites to ensure consistent decision making across all sites. We have
learned that these processes need constant monitoring to ensure that the agreements are
successfully implemented.
Sustaining clinician enthusiasm over a long clinical trial is challenging. Quarterly Steering and
Operations Committee conference calls help to bring investigators together to review study
progress and collectively problem solve issues and address competing demands.
A priori, we recognized that since the intervention cannot be blinded, we needed objective,
independently verifiable outcomes to reduce the chance of reaching a biased conclusion.
Although we anticipated many potential sources of bias, one area of concern was bias towards
under-reporting of adverse events in the supine group. We address this potential source of bias
by intense monitoring of all events by the principal investigator, project manager, study monitor
and DSMB.
Finally, mirroring clinical practice, this study has required the unique collaboration of nurses,
physicians and respiratory therapists. Many uncompensated hours have been volunteered by
clinicians seeking an answer, regardless of outcome, to the question – “Is prone positioning
worth doing?” While multidisciplinary clinical research is a priority for the National Institute
of Health (http://nihroadmap.nih.gov/overview.asp), this study provided many with their first
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opportunity to participate in the process. The most difficult aspect, without doubt, was
navigating systems designed to support non-clinical research.
In conclusion, this paper presents the design and implementation of a multisite clinical trial in
pediatric critical care. The study is presented in detail to allow a comprehensive comparison
with other ALI/ARDS clinical studies and to assist future pediatric critical care scientists in
the conduct of clinical trails.
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Appendix 1: Participating Centers
Children’s Hospital Boston: John H. Arnold MD; John E. Thompson RRT; Michelle
LaBrecque RN, MSN. Children’s Memorial Hospital, Chicago: Lauren Sorce RN, MSN; David
Steinhorn MD. Primary Children’s Medical Center: Mary Jo Chellis Grant RN, PNP, PhD;
Chris Maloney MD. University of California, San Francisco: Jorge Gutierrez MD; Lori D.
Fineman RN, MS; Michael A. Matthay MD. Vanderbilt Children’s Hospital: Rick Barr MD;
Jade Forlidus, RN, MS; Children’s Medical Center of Dallas: Peter M. Luckett, MD; Shirley
Molitor-Kirsch RN, MSN. Children’s Hospital Oakland: Natalie Cvijanovich MD; Lori Wertz
RN, MSN. Duke Children’s Hospital: Ira Cheifetz MD; Donna Hamel RRT. University of
Virginia Children’s Medical Center: Douglas F. Willson MD; Mary Hostetter, RN, CCRN;
Tina Knicely, RN, CCRN. Children’s Hospital St. Louis: Barry P. Markovitz, MD; Rebecca
Snider, RN. Penn State Children’s Hospital: Neal J. Thomas, M.D; Lorri Phipps R.N., CPNP.
All Children’s Hospital: Bonnie Rice RN, MSN, CCNS; Michelle Smith, M.D.
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Figure 1.

Study Schema
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Figure 2.

Ventilator Management
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Figure 3.

Extubation Readiness Test
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Table 1

Inclusion Criteria
1

Age ≥ 42 weeks post-conceptual age and < 18 years of age at study entry

2

All of the following at the same time:
a.

Acute pulmonary parenchymal disease (i.e., chest radiograph with report indicating diffuse bilateral pulmonary alveolar infiltrates)

b.

Intubated and mechanically ventilated for at least 1 hour and anticipated need to continue mechanical ventilation for at least 24
hours

c.

At least one PF ratio ≤ 300 regardless of mean airway pressure (adjusted for barometric pressure)

3

Less than 48 hours from the time“a” through “c” above are present

4

Functional arterial catheter for blood gas analysis
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Table 2

Exclusion Criteria
1

Persistent hypotension - defined as systolic blood pressure of less than 70mmHg + 2 times age in years: specifically, patients requiring either
intravenous fluids and/or increases of additional cardiotonic medications every 2 hours. This criterion may resolve with the 48 hour enrollment
window.

2

Active bleeding that requires blood/fluid volume replacement. This criterion may resolve with the 48 hour enrollment window.

3

Respiratory failure presumed to be the result of cardiac disease (i.e. clinical signs of left ventricular failure, either by echocardiogram or by
pulmonary capillary wedge pressure > 18mmHg)

4

Symptomatic or uncorrected congenital heart disease or a right to left intracardiac shunt5. Currently on extracorporeal membrane oxygenation
(ECMO)

5

Severe chronic lung disease (oxygen and diuretic dependence - i.e. cystic fibrosis or bronchopulmonary dysplasia)

6

Upper airways disease (e.g. tracheitis, tracheomalacia)

7

Reactive airways disease (i.e., asthmatic receiving beta agonists or acute doses of systemic corticosteroids)

8

Restrictive lung disease (i.e. severe scoliosis with abnormal pulmonary function tests)

9

Neuromuscular respiratory failure (i.e. chronic assisted ventilation)

10

Bone marrow or lung transplant

11

Refractory cerebral hypertension (i.e., ICP ≥ 20mmHg for 1 hour)

12

Spinal instability (e.g. uncleared cervical spine)

13

Unstable long bone fracture(s)

14

Draining abdominal surgical wound

15

Third trimester of pregnancy (able to palpate fundus)

16

Nonpulmonary condition that may be exacerbated by the prone position (i.e. osteogenesis imperfecta, craniofacial surgery in the past week)

17

Patient’s family and medical team have decided not to provide full support (patient treatment considered futile)

18

Enrollment in any other clinical trial concurrently or within the last 30 days
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